China Sxt Pharmaceuticals, Inc. (SXTC)
4.10
-0.70
(-14.58%)
USD |
NASDAQ |
Oct 23, 16:00
0.04
-4.06
(-99.02%)
After-Hours: 20:00
China Sxt Pharmaceuticals Enterprise Value : 3.656M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.656M |
| October 22, 2026 | 4.326M |
| October 21, 2026 | 6.721M |
| October 20, 2026 | 5.984M |
| October 19, 2026 | 10.38M |
| October 16, 2026 | 5.955M |
| October 15, 2026 | 6.319M |
| October 14, 2026 | 6.290M |
| October 13, 2026 | 7.143M |
| October 12, 2026 | 9.500M |
| October 09, 2026 | 13.97M |
| October 08, 2026 | 32.64M |
| October 07, 2026 | 270.87M |
| October 06, 2026 | 119.49M |
| October 05, 2026 | 199.01M |
| October 02, 2026 | 230.63M |
| October 01, 2026 | 283.32M |
| September 30, 2026 | 288.12M |
| September 29, 2026 | 268.95M |
| September 28, 2026 | 241.17M |
| September 25, 2026 | 245.96M |
| September 24, 2026 | 244.04M |
| September 23, 2026 | 240.21M |
| September 22, 2026 | 236.38M |
| September 21, 2026 | 227.76M |
| Date | Value |
|---|---|
| September 18, 2026 | 229.67M |
| September 17, 2026 | 233.02M |
| September 16, 2026 | 209.55M |
| September 15, 2026 | 225.84M |
| September 14, 2026 | 254.58M |
| September 11, 2026 | 245.00M |
| September 10, 2026 | 184.64M |
| September 09, 2026 | 204.76M |
| September 08, 2026 | 214.34M |
| September 04, 2026 | 213.38M |
| September 03, 2026 | 210.51M |
| September 02, 2026 | 212.43M |
| September 01, 2026 | 235.42M |
| August 31, 2026 | 245.00M |
| August 28, 2026 | 287.16M |
| August 27, 2026 | 331.23M |
| August 26, 2026 | 340.81M |
| August 25, 2026 | 342.73M |
| August 24, 2026 | 363.81M |
| August 21, 2026 | 392.55M |
| August 20, 2026 | 347.52M |
| August 19, 2026 | 434.70M |
| August 18, 2026 | 491.23M |
| August 17, 2026 | 359.01M |
| August 14, 2026 | 414.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANBC, Inc. | -- |
| China Pharma Holdings, Inc. | 30.29M |
| BioStar Pharmaceuticals, Inc. | -- |
| NeoRich BioPharma Tech Co., Ltd. | 0.0769M |
| China Medicine Corp. | 1.678M |
Enterprise Value Related Metrics
| Earnings Yield | -196.6% |
| Normalized Earnings Yield | -177.88 |